Review
Copyright ©The Author(s) 2024.
World J Hepatol. Apr 27, 2024; 16(4): 566-600
Published online Apr 27, 2024. doi: 10.4254/wjh.v16.i4.566
Table 5 Effects and molecular mechanisms underlying ZnONPs induced hepatonanotoxicity
NPs
Size
Tested model
Dose & route of administration
Effects & mechanism
Ref.
ZnO NPsMicro size; Nano size 63 nm (SEM)Sprague Dawley rat5, 50, 300, 100, 2000 mg/kg b.w for 14 d (oral) AST, ALT (increased)[20]
ZnO NPs35 nm (TEM)Wistar albino rats2 mg/kg b.w. for 21; Days (i.p.)Histopathological alterations; Kupffer cell activation[106]
Inflammation
ZnO NPs50 nm (TEM)Wistar albino rats600 mg/kg/b.w and 1 g/kg/b.w for 5 dALT, NO, TNF-α, IL-6, CRP, IgG (increased)[107]
Inflammation
ZnO NPs80 nm (TEM)C57BL/6 mice200 mg/kg/d (low dose) and 400 mg/kg/d (high dose) for 90 d (oral)ALT, AST (increased); grp78, grp94, pdi-3, xbp-1(increased ER stress related proteins); Increased phosphorylation of PERK & eIF2α; caspase-3, 9, 12 (apoptosis); phosphorylation of JNK, and CHOP/GADD153; upregulation of Chop, Bax[105]
ERstress mediated activation of apoptotic pathway
ZnO NPs30 nm (TEM)HepG2 cell14–20 μg/mL for 12 hAST, ALT, Bax (increased) Bcl2 (decreased) LDH leakage; JNK, P38 activation[108]
Apoptosis
ZnO NPsLess than 15 nm (TEM)Sprague dawley albino rats100, 200, 300 mg/kg b.w. per day for 14 d (oral) ALT, AST, ALP (increased); Bax, caspase-3 (increased); Bcl2 (decreased); Modulation of JNK/p38MAPK & STAT-3 signalling pathways[109]
Apoptosis
ZnO NPs20-50 nm (TEM)HepG2 cells; sprague dawley rat20 μg/mL for 24 h; 25 mg/kg b.w. for 7 d (i.p.)Cell inactivation; Intracellular calcium overload; Mitochondrial damage[110]
Oxidative stress